Literature DB >> 24525231

The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.

Verline Justilien1, Michael P Walsh1, Syed A Ali1, E Aubrey Thompson1, Nicole R Murray1, Alan P Fields2.   

Abstract

We report that two oncogenes coamplified on chromosome 3q26, PRKCI and SOX2, cooperate to drive a stem-like phenotype in lung squamous cell carcinoma (LSCC). Protein kinase Cι (PKCι) phosphorylates SOX2, a master transcriptional regulator of stemness, and recruits it to the promoter of Hedgehog (Hh) acyltransferase (HHAT) that catalyzes the rate-limiting step in Hh ligand production. PKCι-mediated SOX2 phosphorylation is required for HHAT promoter occupancy, HHAT expression, and maintenance of a stem-like phenotype. Primary LSCC tumors coordinately overexpress PKCι, SOX2, and HHAT and require PKCι-SOX2-HHAT signaling to maintain a stem-like phenotype. Thus, PKCι and SOX2 are genetically, biochemically, and functionally linked in LSCC, and together they drive tumorigenesis by establishing a cell-autonomous Hh signaling axis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24525231      PMCID: PMC3949484          DOI: 10.1016/j.ccr.2014.01.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  68 in total

1.  Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.

Authors:  Roderick P Regala; Capella Weems; Lee Jamieson; John A Copland; E Aubrey Thompson; Alan P Fields
Journal:  J Biol Chem       Date:  2005-07-01       Impact factor: 5.157

2.  PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.

Authors:  S Desai; P Pillai; H Win-Piazza; M Acevedo-Duncan
Journal:  Biochim Biophys Acta       Date:  2011-03-17

3.  Phosphorylation dynamics during early differentiation of human embryonic stem cells.

Authors:  Dennis Van Hoof; Javier Muñoz; Stefan R Braam; Martijn W H Pinkse; Rune Linding; Albert J R Heck; Christine L Mummery; Jeroen Krijgsveld
Journal:  Cell Stem Cell       Date:  2009-08-07       Impact factor: 24.633

4.  Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.

Authors:  Silvia Buonamici; Juliet Williams; Michael Morrissey; Anlai Wang; Ribo Guo; Anthony Vattay; Kathy Hsiao; Jing Yuan; John Green; Beatriz Ospina; Qunyan Yu; Lance Ostrom; Paul Fordjour; Dustin L Anderson; John E Monahan; Joseph F Kelleher; Stefan Peukert; Shifeng Pan; Xu Wu; Sauveur-Michel Maira; Carlos García-Echeverría; Kimberly J Briggs; D Neil Watkins; Yung-mae Yao; Christoph Lengauer; Markus Warmuth; William R Sellers; Marion Dorsch
Journal:  Sci Transl Med       Date:  2010-09-29       Impact factor: 17.956

5.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

6.  Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer.

Authors:  Aik T Ooi; Vei Mah; Derek W Nickerson; Jennifer L Gilbert; Vi Luan Ha; Ahmed E Hegab; Steve Horvath; Mohammad Alavi; Erin L Maresh; David Chia; Adam C Gower; Marc E Lenburg; Avrum Spira; Luisa M Solis; Ignacio I Wistuba; Tonya C Walser; William D Wallace; Steven M Dubinett; Lee Goodglick; Brigitte N Gomperts
Journal:  Cancer Res       Date:  2010-08-15       Impact factor: 12.701

7.  A paracrine requirement for hedgehog signalling in cancer.

Authors:  Robert L Yauch; Stephen E Gould; Suzie J Scales; Tracy Tang; Hua Tian; Christina P Ahn; Derek Marshall; Ling Fu; Thomas Januario; Dara Kallop; Michelle Nannini-Pepe; Karen Kotkow; James C Marsters; Lee L Rubin; Frederic J de Sauvage
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

8.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

9.  Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling.

Authors:  Elissaveta Petrova; Jessica Rios-Esteves; Ouathek Ouerfelli; J Fraser Glickman; Marilyn D Resh
Journal:  Nat Chem Biol       Date:  2013-02-17       Impact factor: 15.040

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  145 in total

Review 1.  The impact of the Cancer Genome Atlas on lung cancer.

Authors:  Jeremy T-H Chang; Yee Ming Lee; R Stephanie Huang
Journal:  Transl Res       Date:  2015-08-10       Impact factor: 7.012

2.  An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.

Authors:  Robert J G Cardnell; Carmen Behrens; Lixia Diao; YouHong Fan; Ximing Tang; Pan Tong; John D Minna; Gordon B Mills; John V Heymach; Ignacio I Wistuba; Jing Wang; Lauren A Byers
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

3.  Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells.

Authors:  Verline Justilien; Kayla C Lewis; Kayleah M Meneses; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

4.  FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.

Authors:  Kaixuan Wang; Wenxiang Ji; Yongfeng Yu; Ziming Li; Xiaomin Niu; Weiliang Xia; Shun Lu
Journal:  Oncogene       Date:  2018-06-01       Impact factor: 9.867

5.  Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter.

Authors:  Taketoshi Kajimoto; Alisha D Caliman; Irene S Tobias; Taro Okada; Caila A Pilo; An-Angela N Van; J Andrew McCammon; Shun-Ichi Nakamura; Alexandra C Newton
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

6.  "Atypical" regulation of Hedgehog-dependent cancers.

Authors:  Scott X Atwood; Anthony E Oro
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

7.  Membrane topology of hedgehog acyltransferase.

Authors:  Armine Matevossian; Marilyn D Resh
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

8.  Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.

Authors:  Ning Yin; Yi Liu; Andras Khoor; Xue Wang; E Aubrey Thompson; Michael Leitges; Verline Justilien; Capella Weems; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2019-08-01       Impact factor: 31.743

9.  miR-217-5p induces apoptosis by directly targeting PRKCI, BAG3, ITGAV and MAPK1 in colorectal cancer cells.

Authors:  Marion Flum; Michael Kleemann; Helga Schneider; Benjamin Weis; Simon Fischer; René Handrick; Kerstin Otte
Journal:  J Cell Commun Signal       Date:  2017-09-14       Impact factor: 5.782

10.  A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer.

Authors:  M Catherine Pietanza; Anya M Litvak; Anna M Varghese; Lee M Krug; Martin Fleisher; Jerrold B Teitcher; Andrei I Holodny; Cami S Sima; Kaitlin M Woo; Kenneth K Ng; Helen H Won; Michael F Berger; Mark G Kris; Charles M Rudin
Journal:  Lung Cancer       Date:  2016-04-26       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.